Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Prepaid Assets (2022 - 2025)

Stoke Therapeutics (STOK) has 4 years of Prepaid Assets data on record, last reported at $7.7 million in Q3 2025.

  • For Q3 2025, Prepaid Assets fell 21.25% year-over-year to $7.7 million; the TTM value through Sep 2025 reached $7.7 million, down 21.25%, while the annual FY2024 figure was $2.3 million, 79.71% down from the prior year.
  • Prepaid Assets reached $7.7 million in Q3 2025 per STOK's latest filing, up from $6.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $13.2 million in Q2 2022 and bottomed at $2.3 million in Q4 2024.
  • Average Prepaid Assets over 4 years is $8.3 million, with a median of $9.8 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: soared 283.08% in 2023, then crashed 79.71% in 2024.
  • A 4-year view of Prepaid Assets shows it stood at $3.0 million in 2022, then skyrocketed by 283.08% to $11.3 million in 2023, then tumbled by 79.71% to $2.3 million in 2024, then skyrocketed by 237.27% to $7.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $7.7 million in Q3 2025, $6.9 million in Q2 2025, and $12.7 million in Q1 2025.